Xynergy
Natural health product licensed in Canada
- Licence holder
- 1123573 BC Ltd.
- NPN or DIN-HM
- 80046722
- Status
- Inactive licence
- Licence date
- 29 November 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
arrêté du 16 avril 2026 (JORFTEXT000053907152). French orders suspending food supplements containing a plant (Official Journal), checked against the text, retrieved 23 October 2026.
Order published in the French Official Journal, read on Légifrance.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Extraction ratio : 25:1 Dry plant equivalent : 5,000 mg Potency : 36 % Epigallocatechin 3-gallate | 200 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 20 % Caffeine | Not specified | Not calculated |
| Eleutherococcus senticosus Source : Racine | 12.5 mg | Not calculated |
| Iode Source : Ascophyllum nodosum - whole | 8.8 microgrammes | Not calculated |
| Garcinia gummi-gutta Source : Écorce du fruit Potency : 50 % Hydroxycitric acid | 375 mg | Not calculated |
| Zingiber officinale Source : Racine | 12.5 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 2 days |
Uses authorised in Canada
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Discontinue use if you experience anxiety or insomnia.
- Précautions et mises en garde
Do not use if you are pregnant or breastfeeding. This product may aggravate the condition of existing gastro-intestinal ulcers. Consult a health care practitioner prior to use if you are taking blood thinning medication. Consult a health care practitioner prior to use if you have a serious medical condition, such as heart disease, kidney disease, or an overactive thyroid. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble. Consult a health care practitioner prior to use if you have an iron deficiency. Do not use if you have high blood pressure or are taking blood pressure medications (eg. hypertensives or anti-hypertensives), thyroid medications, sympathomimetrics, or monoamine oxidase inhibitors (MAOIs). If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use. If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product.
Source
Official Health Canada record, licence 80046722
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.